These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 14616693)
1. Antibiotic susceptibility of isolates of Bacillus anthracis, a bacterial pathogen with the potential to be used in biowarfare. Jones ME; Goguen J; Critchley IA; Draghi DC; Karlowsky JA; Sahm DF; Porschen R; Patra G; DelVecchio VG Clin Microbiol Infect; 2003 Sep; 9(9):984-6. PubMed ID: 14616693 [TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibilities of 40 isolates of Bacillus anthracis isolated in Turkey. Esel D; Doganay M; Sumerkan B Int J Antimicrob Agents; 2003 Jul; 22(1):70-2. PubMed ID: 12842331 [TBL] [Abstract][Full Text] [Related]
3. Impact of spores on the comparative efficacies of five antibiotics for treatment of Bacillus anthracis in an in vitro hollow fiber pharmacodynamic model. Louie A; VanScoy BD; Brown DL; Kulawy RW; Heine HS; Drusano GL Antimicrob Agents Chemother; 2012 Mar; 56(3):1229-39. PubMed ID: 22155821 [TBL] [Abstract][Full Text] [Related]
4. Omadacycline is active Heine HS; Drusano G; Purcell BK; Anastasiou D; Tanaka SK; Serio AW Antimicrob Agents Chemother; 2024 Sep; 68(9):e0059524. PubMed ID: 39133023 [No Abstract] [Full Text] [Related]
5. Evaluation of Manzulli V; Fasanella A; Parisi A; Serrecchia L; Donatiello A; Rondinone V; Caruso M; Zange S; Tscherne A; Decaro N; Pedarra C; Galante D J Vet Sci; 2019 Jan; 20(1):58-62. PubMed ID: 30541185 [TBL] [Abstract][Full Text] [Related]
7. Updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to Bacillus anthracis. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(43):960. PubMed ID: 11708594 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits. Weiss S; Altboum Z; Glinert I; Schlomovitz J; Sittner A; Bar-David E; Kobiler D; Levy H Antimicrob Agents Chemother; 2015 Dec; 59(12):7497-503. PubMed ID: 26392505 [TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility of Bacillus anthracis strains from Hungary. Kreizinger Z; Sulyok KM; Makrai L; Rónai Z; Fodor L; Jánosi S; Gyuranecz M Acta Vet Hung; 2016 Jun; 64(2):141-7. PubMed ID: 27342086 [TBL] [Abstract][Full Text] [Related]
10. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(42):909-19. PubMed ID: 11699843 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility testing of Bacillus anthracis: comparison of results obtained by using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods. Mohammed MJ; Marston CK; Popovic T; Weyant RS; Tenover FC J Clin Microbiol; 2002 Jun; 40(6):1902-7. PubMed ID: 12037041 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of linezolid and ciprofloxacin on toxin production by Bacillus anthracis in an in vitro pharmacodynamic system. Louie A; Vanscoy BD; Heine HS; Liu W; Abshire T; Holman K; Kulawy R; Brown DL; Drusano GL Antimicrob Agents Chemother; 2012 Jan; 56(1):513-7. PubMed ID: 22064542 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility and molecular subtyping of 55 Turkish Bacillus anthracis strains using 25-loci multiple-locus VNTR analysis. Ortatatli M; Karagoz A; Percin D; Kenar L; Kilic S; Durmaz R Comp Immunol Microbiol Infect Dis; 2012 Jul; 35(4):355-61. PubMed ID: 22445310 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of Combination Drug Therapy for Treatment of Antibiotic-Resistant Inhalation Anthrax in a Murine Model. Heine HS; Shadomy SV; Boyer AE; Chuvala L; Riggins R; Kesterson A; Myrick J; Craig J; Candela MG; Barr JR; Hendricks K; Bower WA; Walke H; Drusano GL Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696235 [No Abstract] [Full Text] [Related]
15. Antibiotic susceptibilities of 96 isolates of Bacillus anthracis isolated in France between 1994 and 2000. Cavallo JD; Ramisse F; Girardet M; Vaissaire J; Mock M; Hernandez E Antimicrob Agents Chemother; 2002 Jul; 46(7):2307-9. PubMed ID: 12069996 [TBL] [Abstract][Full Text] [Related]
16. From the Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. JAMA; 2001 Nov; 286(18):2226-32. PubMed ID: 11757528 [No Abstract] [Full Text] [Related]
17. Susceptibility to antibiotics of Bacillus anthracis strains isolated in Romania. Caplan DM; Ivana S; Caplan ME Roum Arch Microbiol Immunol; 2009; 68(2):106-10. PubMed ID: 20361530 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of Bacillus anthracis in an endemic area. Bakici MZ; Elaldi N; Bakir M; Dökmetaş I; Erandaç M; Turan M Scand J Infect Dis; 2002; 34(8):564-6. PubMed ID: 12238569 [TBL] [Abstract][Full Text] [Related]
19. MICs of selected antibiotics for Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis, and Bacillus mycoides from a range of clinical and environmental sources as determined by the Etest. Turnbull PC; Sirianni NM; LeBron CI; Samaan MN; Sutton FN; Reyes AE; Peruski LF J Clin Microbiol; 2004 Aug; 42(8):3626-34. PubMed ID: 15297508 [TBL] [Abstract][Full Text] [Related]
20. Characterization of Bacillus anthracis-like bacteria isolated from wild great apes from Cote d'Ivoire and Cameroon. Klee SR; Ozel M; Appel B; Boesch C; Ellerbrok H; Jacob D; Holland G; Leendertz FH; Pauli G; Grunow R; Nattermann H J Bacteriol; 2006 Aug; 188(15):5333-44. PubMed ID: 16855222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]